Texas Attorney General Ken Paxton has initiated legal action against Johnson & Johnson and its spin-off company Kenvue, contending that the pharmaceutical companies neglected to inform consumers about the potential risks associated with the use of Tylenol during pregnancy. The lawsuit, announced on October 28, specifically points to alleged links between Tylenol and conditions such as autism and attention deficit hyperactivity disorder (ADHD), which Paxton argues constitute a violation of Texas consumer protection laws.
In his statement, Paxton expressed strong allegations against the corporations, stating, “These corporations lied for decades, knowingly endangering millions to line their pockets.” He also criticized Johnson & Johnson for attempting to distance itself from liability by transferring responsibility to its subsidiary. Paxton’s pursuit of legal action reflects a broader initiative to hold major pharmaceutical companies accountable for what he describes as negligence that has potentially harmed countless individuals.
This lawsuit underscores ongoing concerns regarding the safety of widely used medications and their long-term effects, especially for vulnerable populations such as pregnant women. It also highlights the challenge of ensuring that pharmaceutical companies uphold ethical standards in sharing crucial health information with consumers. Paxton’s push for accountability aims not only to protect public health but also to enforce stricter regulations within the pharmaceutical industry, reinforcing a commitment to consumer safety.